Evidence map›Paper›PMID 31978117›Full record

ArticlePloS one2020

A prospective case-control study on miRNA circulating levels in subjects born small for gestational age (SGA) evaluated from childhood into young adulthood.

Elena Inzaghi, Anna Kistner, Daniela Germani, Annalisa Deodati, Mireille Vanpee, Lena Legnevall, Katarina Berinder, Stefano Cianfarani

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Elena InzaghiDipartimento Pediatrico Universitario Ospedaliero, "Bambino Gesù" Children's Hospital - Tor Vergata University, Rome, Italy.ORCID 0000-0002-8315-5168
Anna KistnerDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Daniela GermaniDipartimento di Medicina dei Sistemi, University of Rome Tor vergata, Rome, Italy.
Annalisa DeodatiDipartimento Pediatrico Universitario Ospedaliero, "Bambino Gesù" Children's Hospital - Tor Vergata University, Rome, Italy.
Mireille VanpeeDepartment of Women's and Children's Health, Karolinska Institutet and University Hospital, Stockholm, Sweden.
Lena LegnevallDepartment of Women's and Children's Health, Karolinska Institutet and University Hospital, Stockholm, Sweden.
Katarina BerinderDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Stefano CianfaraniDipartimento Pediatrico Universitario Ospedaliero, "Bambino Gesù" Children's Hospital - Tor Vergata University, Rome, Italy.
Karolinska Institutet · SEBambino Gesù Children's Hospital · ITKarolinska University Hospital · SEUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivemicroRNAs (miRNAs) associated with metabolic risk have never been extensively investigated in SGA subjects. The aim of the current study was to evaluate miRNAs in SGA and AGA subjects and their relationships with the metabolic status and growth. DESIGN AND

methodsA prospective longitudinal case-control study was performed in 23 SGA with postnatal catch-up growth and 27 AGA subjects evaluated at the age of 9 and 21 years. Circulating levels of miR-122-5p, miR-16-5p, miR-126-3p, and miR-486-5p were assessed by qPCR.

resultsSGA subjects were shorter both at 9 and at 21 years. No significant differences in insulin like growth factors and metabolic profile were found with the exception of basal glycemia at 9 years. miRNA levels did not differ between SGA and AGA subjects, at 9 and 21 years. miR-16-5p and miR-126-3p levels were higher at 9 than at 21 years. In SGA subjects, miR-122-5p at 9 years was inversely related to adiponectin levels at 21 years and miR-486-5p at 9 years was inversely related to whole-body insulin sensitivity at 9 years and directly related to Hb1Ac at 21 years. Regression analyses showed no predictive value of miRNAs for growth parameters in neither SGA nor AGA subjects.

conclusionsSGA with postnatal catch-up growth did not show any difference in metabolic risk markers or miRNA circulating levels compared to AGA controls in childhood and young adulthood. miR-122-5p during childhood could identify SGA subjects at higher risk of developing insulin resistance and, eventually, type 2 diabetes in adulthood but further studies are needed to confirm it.

Indexed as

AdiponectinAdolescentCase-Control StudiesChildCirculating MicroRNAFemaleGene Expression RegulationGlycated HemoglobinHumansInfant, Small for Gestational AgeInsulin ResistanceMaleProspective StudiesRegression AnalysisYoung AdultAdiponectinCirculating MicroRNAGlycated Hemoglobin

Identifiers

PMID31978117
PMCPMC6980597
OpenAlexW3002534509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.